• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CareDx, Inc. - Common Stock (NQ:CDNA)

45.32 -2.06 (-4.35%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CareDx, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 07, 2026
From CareDx, Inc.
Via Business Wire
CareDx (NASDAQ:CDNA) Posts Accelerating Growth and Strengthening Fundamentals ↗
August 06, 2026
Via Chartmill
News headline image
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 31, 2026
From CareDx, Inc.
Via Business Wire
News headline image
Why CareDx Stock Jumped Today ↗
July 31, 2026
The diagnostics leader is accelerating the trend toward precision medicine. 
Via The Motley Fool
News headline image
CareDx Q2 Earnings Call Highlights ↗
July 30, 2026
CareDx (NASDAQ:CDNA) reported second-quarter 2026 revenue growth of 52% as the transplant diagnostics company expanded testing services, completed the sale of its lab products business and began... 
Via MarketBeat
Topics Earnings
CareDx (NASDAQ:CDNA) Passes Both the Minervini Trend Template and High Growth Momentum Tests ↗
June 20, 2026
Via Chartmill
CAREDX INC (NASDAQ:CDNA) Shows Perfect Minervini Trend Template and High Growth Momentum Setup ↗
May 30, 2026
Via Chartmill
CareDx (NASDAQ:CDNA) Beats Q1 Estimates and Raises Full-Year Guidance, But Stock Slips ↗
April 28, 2026
Via Chartmill
News headline image
CareDx Announces Second Quarter 2026 Financial Results
July 30, 2026
From CareDx, Inc.
Via Business Wire
What's going on in today's session ↗
July 16, 2026
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
July 16, 2026
Via Chartmill
News headline image
CareDx to Report Second Quarter 2026 Financial Results on July 30, 2026
July 16, 2026
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Finalization of Solid Organ Transplant Molecular Testing Local Coverage Determination
July 16, 2026
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Completes Acquisition of Naveris, Extending Leadership into High-Growth Specialty Oncology
July 01, 2026
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Completion of Sale of Lab Products Business to Eurobio Scientific
June 30, 2026
From CareDx, Inc.
Via Business Wire
News headline image
CareDx's CEO Sells 17K Shares ↗
June 21, 2026
CareDx, a leader in transplant diagnostics, saw a key insider reduce his direct holdings amid a series of scheduled transactions. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress
June 18, 2026
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology
June 16, 2026
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Sharpens Precision Diagnostics Push With Naveris Deal, AlloHeme Plans ↗
June 08, 2026
CareDx (NASDAQ:CDNA) executives outlined the company’s strategy to focus on precision diagnostics, expand into minimal residual disease testing and improve profitability during a Goldman Sachs-hosted... 
Via MarketBeat
Topics Intellectual Property
News headline image
CareDx Highlights 39% Q1 Growth, Naveris Oncology Push at Jefferies ↗
June 07, 2026
CareDx (NASDAQ:CDNA) executives outlined the company’s growth strategy, first-quarter performance and pipeline priorities during a presentation at the Jefferies Healthcare Conference, emphasizing... 
Via MarketBeat
News headline image
CareDx to Participate in Upcoming Investor Conferences
May 20, 2026
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Dismissal of 2021 Qui Tam Suit
May 11, 2026
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 01, 2026
From CareDx, Inc.
Via Business Wire
News headline image
CareDx (CDNA) Q1 2026 Earnings Call Transcript ↗
April 28, 2026
CareDx (CDNA) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
April 28, 2026
Via Chartmill
News headline image
CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing
April 28, 2026
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Announces First Quarter 2026 Financial Results
April 28, 2026
From CareDx, Inc.
Via Business Wire
News headline image
CareDx (CDNA) Q2 2025 Earnings Transcript ↗
April 28, 2026
CareDx (CDNA) Q2 2025 Earnings Transcript 
Via The Motley Fool
News headline image
CareDx Announces Presentation of More Than 50 Abstracts Including 16 Oral Presentations at the International Society for Heart and Lung Transplantation’s 46th Annual Meeting
April 21, 2026
From CareDx, Inc.
Via Business Wire
News headline image
CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing
April 20, 2026
From CareDx, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap